|
1
|
Cohen MS and Moley JF: Surgical treatment
of medullary thyroid carcinoma. J Intern Med. 253:616–626. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Minemura K, Takeda T, Nagasawa T, Zhang R,
Leopardi R and DeGroot LJ: Cell-specific induction of sensitivity
to ganciclovir in medullary thyroid carcinoma cells by
adenovirus-mediated gene transfer of herpes simplex virus thymidine
kinase. Endocrinology. 141:1814–1822. 2000.PubMed/NCBI
|
|
3
|
Soler MN, Milhaud G, Lekmine F,
Treilhou-Lahille F, Klatzmann and Lausson S: Treatment of medullary
thyroid carcinoma by combined expression of suicide and
interleukin-2 genes. Cancer Immunol Immunother. 48:91–99. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shi Z, Chen J, Li CY, An N, Wang ZJ, Yang
SL, Huang KF and Bao JK: Antitumor effects of concanavalin A and
Sophora flavescens Iectin in vitro and in vivo. Acta Pharmcol Sin.
35:248–256. 2014. View Article : Google Scholar
|
|
5
|
Zhang LH, Wang H, Ma GL, Zhang C, Sun HX,
Song CX and Kong DS: Study on antitumor activity of
paclitaxel-loaded polymeric micelles. Int J Biomed Eng. 37:12–17.
2014.
|
|
6
|
Hashimoto S, Xu M, Masuda Y, Aiuchi T,
Nakajo S, Cao J, Miyakoshi M, Ida Y and Nakaya K:
Beta-hydroxyisovalerylshikonin inhibits the cell growth of various
cancer cell lines and induces apoptosis in leukemia HL-60 cells
through a mechanism different from those of Fas and etoposide. J
Biochem. 125:17–23. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang H, Zhou P, Huang H, Chen D, Ma N, Cui
QC, Shen S, Dong W, Zhang X, Lian W, et al: Shikonin exerts
antitumor activity via proteasome inhibition and cell death
induction in vitro and in vivo. Int J Cancer. 124:2450–2459. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu PC, Huang YT, Tsai ML, Wang YJ, Lin JK
and Pan MH: Induction of apoptosis by shikonin through coordinative
modulation of the Bcl-2 family, p27 and p53, release of cytochrome
c and sequential activation of caspases in human colorectal
carcinoma cells. J Agric Food Chem. 52:6330–6337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nam KN, Son MS, Park JH and Lee EH:
Shikonins attenuate microglial inflammatory responses by inhibition
of ERK, Akt and NF-kappaB: Neuroprotective implications.
Neuropharmacology. 55:819–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Min R, Tong J, Wenjun Y, Wenhu D, Xiaojian
Z, Jiacai H, Jian Z, Wantao C and Chenping Z: Growth inhibition and
induction of apoptosis in human oral squamous cell carcinoma
Tca-8113 cell lines by Shikonin was partly through the inactivation
of NF-kappaB pathway. Phytother Res. 22:407–415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang IC, Huang YJ, Chiang TI, Yeh CW and
Hsu LS: Shikonin induces apoptosis through reactive oxygen
species/extracellular signal-regulated kinase pathway in
osteosarcoma cells. Biol Pharm Bull. 33:816–824. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu L, Qin A, Huang H, Zhou P, Zhang C, Liu
N, Li S, Wen G, Zhang C, Dong W, et al: Shikonin extracted from
medicinal Chinese herbs exerts anti-inflammatory effect via
proteasome inhibition. Eur J Pharmacol. 658:242–247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wiench B, Eichhorn T, Paulsen M and
Efferth T: Shikonin directly targets mitochondfia and causes
mitochondrial dysfunction in cancer cells. Evid Based Complement
Alteruat Med. 2012:7260252012.
|
|
14
|
Staniforth V, Wang SY, Shyur LF and Yang
NS: Shikonins, phytocompounds from Lithospermum erythrorhizon,
inhibit the transcriptional activation of human tumor necrosis
factor alpha promoter in vivo. J Biol Chem. 279:5877–5885. 2004.
View Article : Google Scholar
|
|
15
|
Hu X and Xuan Y: Bypassing cancer drug
resistance by activating multiple death pathways-a proposal from
the study of circumventing cancer drug resistance by induction of
necroptosis. Cancer Lett. 259:127–137. 2008. View Article : Google Scholar
|
|
16
|
Xuan Y and Hu X: Naturally-occurring
shikonin analogues-a class of necroptotic inducers that circumvent
cancer drug resistance. Cancer Lett. 274:233–242. 2009. View Article : Google Scholar
|
|
17
|
Villena J, Madrid A, Montenegro I, Werner
E, Cuellar M and Espinoza L: Diterpenylhydroquinones from natural
ent-labdanes induce apoptosis through decreased mitochondrial
membrane potential. Molecules. 18:5348–5359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sankawa U, Ebizuka Y, Miyazaki T, Isomura
Y and Otsuka H: Antitumor activity of shikonin and its derivatives.
Chem Pharm Bull (Tokyo). 25:2392–2395. 1977. View Article : Google Scholar
|
|
19
|
Kleibl Z, Raisová M, Novotný J, Pohlreich
P and Matous B: Apoptosis and its importance in the development and
therapy of tumors (review). Sb Lek. 103:1–13. 2002.In Czech.
|
|
20
|
Yingkun N, Lvsong Z and Huimin Y: Shikonin
inhibits the proliferation and induces the apoptosis of human HepG2
cells. Can J Physiol Pharmacol. 88:1138–1146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Z, Wu L, Li L, Tashiro S, Onodera S and
Ikejima T: P53-mediated cell cycle arrest and apoptosis induced by
shikonin via a caspase-9-dependent mechanism in human malignant
melanoma A375-S2 cells. J Pharmacol Sci. 94:166–176. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thangapazham RL, Singh AK, Seth P, Misra
N, Mathad VT, Raj K and Maheshwari RK: Shikonin analogue (SA)
93/637 induces apoptosis by activation of caspase-3 in U937 cells.
Front Biosci. 13:561–568. 2008. View
Article : Google Scholar
|
|
23
|
Yeh CC, Kuo HM, Li TM, Lin JP, Yu FS, Lu
HF, Chung JG and Yang JS: Shikonin-induced apoptosis involves
caspase-3 activity in a human bladder cancer cell line (T24). In
Vivo. 21:1011–1019. 2007.
|
